MAPK8 and Alzheimer disease: Genetic or drug-mediated diminution of either calcineurin or JNK function aids cognitive preservation; as a clinical correlate, organ transplant recipients treated chronically with the calcineurin inhibitor FK506 have been found to be at notably lower risk for AD [5,22,23].